nodes	percent_of_prediction	percent_of_DWPC	metapath
Mesalazine—Methyldopa—hypertension	0.295	1	CrCtD
Mesalazine—IKBKB—hypertension	0.119	0.492	CbGaD
Mesalazine—Aminosalicylic Acid—Methyldopa—hypertension	0.0447	0.253	CrCrCtD
Mesalazine—ALOX5—hypertension	0.0428	0.176	CbGaD
Mesalazine—PPARG—Telmisartan—hypertension	0.0426	0.353	CbGbCtD
Mesalazine—Carbidopa—Methyldopa—hypertension	0.0336	0.19	CrCrCtD
Mesalazine—Droxidopa—Methyldopa—hypertension	0.029	0.164	CrCrCtD
Mesalazine—Dopamine—Methyldopa—hypertension	0.029	0.164	CrCrCtD
Mesalazine—MPO—hypertension	0.0276	0.114	CbGaD
Mesalazine—PPARG—hypertension	0.0245	0.101	CbGaD
Mesalazine—Salicylamide—Labetalol—hypertension	0.021	0.119	CrCrCtD
Mesalazine—L-DOPA—Methyldopa—hypertension	0.0193	0.109	CrCrCtD
Mesalazine—PTGS1—hypertension	0.0181	0.0745	CbGaD
Mesalazine—PTGS1—Minoxidil—hypertension	0.0177	0.147	CbGbCtD
Mesalazine—PTGS1—Torasemide—hypertension	0.0162	0.134	CbGbCtD
Mesalazine—PTGS1—Candesartan—hypertension	0.0151	0.125	CbGbCtD
Mesalazine—PTGS2—Bumetanide—hypertension	0.0112	0.0933	CbGbCtD
Mesalazine—PTGS2—hypertension	0.0103	0.0426	CbGaD
Mesalazine—PTGS1—Irbesartan—hypertension	0.00931	0.0772	CbGbCtD
Mesalazine—PTGS1—Carvedilol—hypertension	0.00838	0.0695	CbGbCtD
Mesalazine—MPO—superior mesenteric artery—hypertension	0.00558	0.248	CbGeAlD
Mesalazine—PPARG—nephron—hypertension	0.000949	0.0421	CbGeAlD
Mesalazine—PPARG—hindlimb—hypertension	0.000864	0.0384	CbGeAlD
Mesalazine—MPO—artery—hypertension	0.000597	0.0265	CbGeAlD
Mesalazine—PPARG—artery—hypertension	0.00053	0.0235	CbGeAlD
Mesalazine—MPO—endothelium—hypertension	0.000504	0.0224	CbGeAlD
Mesalazine—PTGS2—nephron—hypertension	0.000485	0.0215	CbGeAlD
Mesalazine—MPO—blood vessel—hypertension	0.000465	0.0206	CbGeAlD
Mesalazine—CHUK—heart—hypertension	0.000461	0.0205	CbGeAlD
Mesalazine—PPARG—endothelium—hypertension	0.000447	0.0199	CbGeAlD
Mesalazine—PTGS2—hindlimb—hypertension	0.000441	0.0196	CbGeAlD
Mesalazine—CHUK—cardiovascular system—hypertension	0.000435	0.0193	CbGeAlD
Mesalazine—PPARG—blood vessel—hypertension	0.000413	0.0183	CbGeAlD
Mesalazine—CHUK—adrenal gland—hypertension	0.000344	0.0153	CbGeAlD
Mesalazine—MPO—myocardium—hypertension	0.000315	0.014	CbGeAlD
Mesalazine—IKBKB—heart—hypertension	0.000313	0.0139	CbGeAlD
Mesalazine—IKBKB—smooth muscle tissue—hypertension	0.000311	0.0138	CbGeAlD
Mesalazine—IKBKB—decidua—hypertension	0.000305	0.0135	CbGeAlD
Mesalazine—CHUK—endocrine gland—hypertension	0.000298	0.0133	CbGeAlD
Mesalazine—IKBKB—cardiovascular system—hypertension	0.000296	0.0131	CbGeAlD
Mesalazine—PTGS1—artery—hypertension	0.000283	0.0126	CbGeAlD
Mesalazine—IKBKB—cortex of kidney—hypertension	0.000282	0.0125	CbGeAlD
Mesalazine—PPARG—myocardium—hypertension	0.000279	0.0124	CbGeAlD
Mesalazine—PTGS2—artery—hypertension	0.000271	0.012	CbGeAlD
Mesalazine—ALOX5—heart—hypertension	0.00026	0.0115	CbGeAlD
Mesalazine—ALOX5—smooth muscle tissue—hypertension	0.000258	0.0114	CbGeAlD
Mesalazine—ALOX5—decidua—hypertension	0.000253	0.0112	CbGeAlD
Mesalazine—ALOX5—cardiovascular system—hypertension	0.000245	0.0109	CbGeAlD
Mesalazine—PTGS1—endothelium—hypertension	0.000239	0.0106	CbGeAlD
Mesalazine—IKBKB—adrenal gland—hypertension	0.000234	0.0104	CbGeAlD
Mesalazine—PTGS2—endothelium—hypertension	0.000229	0.0101	CbGeAlD
Mesalazine—PTGS1—blood vessel—hypertension	0.000221	0.00979	CbGeAlD
Mesalazine—MPO—heart—hypertension	0.00022	0.00976	CbGeAlD
Mesalazine—PTGS2—blood vessel—hypertension	0.000211	0.00936	CbGeAlD
Mesalazine—MPO—cardiovascular system—hypertension	0.000207	0.00921	CbGeAlD
Mesalazine—MPO—kidney—hypertension	0.000203	0.00901	CbGeAlD
Mesalazine—IKBKB—endocrine gland—hypertension	0.000203	0.00901	CbGeAlD
Mesalazine—PPARG—heart—hypertension	0.000195	0.00866	CbGeAlD
Mesalazine—ALOX5—adrenal gland—hypertension	0.000194	0.00861	CbGeAlD
Mesalazine—PPARG—smooth muscle tissue—hypertension	0.000193	0.00859	CbGeAlD
Mesalazine—PPARG—decidua—hypertension	0.00019	0.00842	CbGeAlD
Mesalazine—PPARG—cardiovascular system—hypertension	0.000184	0.00817	CbGeAlD
Mesalazine—IKBKB—central nervous system—hypertension	0.000183	0.00812	CbGeAlD
Mesalazine—PPARG—kidney—hypertension	0.00018	0.00799	CbGeAlD
Mesalazine—ALOX5—endocrine gland—hypertension	0.000168	0.00746	CbGeAlD
Mesalazine—MPO—adrenal gland—hypertension	0.000164	0.00728	CbGeAlD
Mesalazine—ALOX5—central nervous system—hypertension	0.000152	0.00673	CbGeAlD
Mesalazine—PTGS1—myocardium—hypertension	0.000149	0.00663	CbGeAlD
Mesalazine—PPARG—adrenal gland—hypertension	0.000146	0.00646	CbGeAlD
Mesalazine—MPO—endocrine gland—hypertension	0.000142	0.00632	CbGeAlD
Mesalazine—Dopamine—DBH—hypertension	0.000138	0.0764	CrCbGaD
Mesalazine—MPO—central nervous system—hypertension	0.000128	0.00569	CbGeAlD
Mesalazine—Olsalazine—ALOX5—hypertension	0.000127	0.0706	CrCbGaD
Mesalazine—PPARG—endocrine gland—hypertension	0.000126	0.0056	CbGeAlD
Mesalazine—Aminosalicylic Acid—ALOX5—hypertension	0.00012	0.0663	CrCbGaD
Mesalazine—PPARG—central nervous system—hypertension	0.000114	0.00505	CbGeAlD
Mesalazine—PTGS1—heart—hypertension	0.000104	0.00463	CbGeAlD
Mesalazine—PTGS1—smooth muscle tissue—hypertension	0.000103	0.00459	CbGeAlD
Mesalazine—PTGS2—adrenal cortex—hypertension	0.000103	0.00458	CbGeAlD
Mesalazine—PTGS2—heart—hypertension	9.97e-05	0.00442	CbGeAlD
Mesalazine—PTGS2—smooth muscle tissue—hypertension	9.89e-05	0.00439	CbGeAlD
Mesalazine—PTGS1—cardiovascular system—hypertension	9.84e-05	0.00437	CbGeAlD
Mesalazine—PTGS1—kidney—hypertension	9.63e-05	0.00427	CbGeAlD
Mesalazine—Methyldopa—COMT—hypertension	9.55e-05	0.0529	CrCbGaD
Mesalazine—PTGS2—cardiovascular system—hypertension	9.4e-05	0.00418	CbGeAlD
Mesalazine—PTGS2—kidney—hypertension	9.2e-05	0.00409	CbGeAlD
Mesalazine—PTGS1—cardiac atrium—hypertension	8.92e-05	0.00396	CbGeAlD
Mesalazine—Droxidopa—ADRA2B—hypertension	8.67e-05	0.0481	CrCbGaD
Mesalazine—PTGS2—medulla oblongata—hypertension	8.04e-05	0.00357	CbGeAlD
Mesalazine—Salicylate-sodium—PTGS1—hypertension	7.85e-05	0.0435	CrCbGaD
Mesalazine—PTGS1—adrenal gland—hypertension	7.78e-05	0.00346	CbGeAlD
Mesalazine—Aminosalicylic Acid—MPO—hypertension	7.71e-05	0.0427	CrCbGaD
Mesalazine—Droxidopa—SLC6A2—hypertension	7.61e-05	0.0422	CrCbGaD
Mesalazine—PTGS2—adrenal gland—hypertension	7.44e-05	0.0033	CbGeAlD
Mesalazine—Olsalazine—PPARG—hypertension	7.28e-05	0.0404	CrCbGaD
Mesalazine—PTGS1—endocrine gland—hypertension	6.75e-05	0.003	CbGeAlD
Mesalazine—PTGS2—endocrine gland—hypertension	6.45e-05	0.00286	CbGeAlD
Mesalazine—Methyldopa—ADRA2A—hypertension	6.08e-05	0.0337	CrCbGaD
Mesalazine—PTGS1—central nervous system—hypertension	6.08e-05	0.0027	CbGeAlD
Mesalazine—Dopamine—SLC6A2—hypertension	5.96e-05	0.033	CrCbGaD
Mesalazine—PTGS2—central nervous system—hypertension	5.81e-05	0.00258	CbGeAlD
Mesalazine—Olsalazine—PTGS1—hypertension	5.38e-05	0.0298	CrCbGaD
Mesalazine—Droxidopa—ADRA1A—hypertension	5.36e-05	0.0297	CrCbGaD
Mesalazine—Diflunisal—PTGS1—hypertension	5.06e-05	0.028	CrCbGaD
Mesalazine—Aminosalicylic Acid—PTGS1—hypertension	5.06e-05	0.028	CrCbGaD
Mesalazine—Dopamine—COMT—hypertension	4.66e-05	0.0258	CrCbGaD
Mesalazine—Salicylate-sodium—PTGS2—hypertension	4.48e-05	0.0249	CrCbGaD
Mesalazine—Droxidopa—ADRA2A—hypertension	3.8e-05	0.0211	CrCbGaD
Mesalazine—Droxidopa—ADRB1—hypertension	3.79e-05	0.021	CrCbGaD
Mesalazine—L-DOPA—DRD3—hypertension	3.5e-05	0.0194	CrCbGaD
Mesalazine—Dopamine—HTR7—hypertension	3.47e-05	0.0192	CrCbGaD
Mesalazine—Dopamine—DRD3—hypertension	3.26e-05	0.0181	CrCbGaD
Mesalazine—Droxidopa—ADRB2—hypertension	3.19e-05	0.0177	CrCbGaD
Mesalazine—Olsalazine—PTGS2—hypertension	3.07e-05	0.017	CrCbGaD
Mesalazine—Dopamine—SLC6A3—hypertension	3.03e-05	0.0168	CrCbGaD
Mesalazine—Dopamine—ADRB1—hypertension	2.97e-05	0.0165	CrCbGaD
Mesalazine—Diflunisal—PTGS2—hypertension	2.89e-05	0.016	CrCbGaD
Mesalazine—Aminosalicylic Acid—PTGS2—hypertension	2.89e-05	0.016	CrCbGaD
Mesalazine—Salicylic acid—PTGS1—hypertension	2.81e-05	0.0156	CrCbGaD
Mesalazine—Diflunisal—ALB—hypertension	2.57e-05	0.0143	CrCbGaD
Mesalazine—L-DOPA—DRD2—hypertension	2.43e-05	0.0134	CrCbGaD
Mesalazine—Dopamine—SLC6A4—hypertension	2.27e-05	0.0126	CrCbGaD
Mesalazine—Dopamine—DRD2—hypertension	2.25e-05	0.0125	CrCbGaD
Mesalazine—Salicylic acid—PTGS2—hypertension	1.61e-05	0.00891	CrCbGaD
Mesalazine—Salicylic acid—ALB—hypertension	1.43e-05	0.00794	CrCbGaD
Mesalazine—Oedema—Timolol—hypertension	5.74e-06	6.51e-05	CcSEcCtD
Mesalazine—Loss of consciousness—Lisinopril—hypertension	5.73e-06	6.5e-05	CcSEcCtD
Mesalazine—Rash—Verapamil—hypertension	5.73e-06	6.5e-05	CcSEcCtD
Mesalazine—Urticaria—Hydrochlorothiazide—hypertension	5.73e-06	6.5e-05	CcSEcCtD
Mesalazine—Tachycardia—Ramipril—hypertension	5.73e-06	6.5e-05	CcSEcCtD
Mesalazine—Dermatitis—Verapamil—hypertension	5.73e-06	6.49e-05	CcSEcCtD
Mesalazine—Headache—Nifedipine—hypertension	5.72e-06	6.49e-05	CcSEcCtD
Mesalazine—Pruritus—Clonidine—hypertension	5.71e-06	6.47e-05	CcSEcCtD
Mesalazine—Abdominal pain—Hydrochlorothiazide—hypertension	5.7e-06	6.47e-05	CcSEcCtD
Mesalazine—Body temperature increased—Hydrochlorothiazide—hypertension	5.7e-06	6.47e-05	CcSEcCtD
Mesalazine—Skin disorder—Ramipril—hypertension	5.7e-06	6.47e-05	CcSEcCtD
Mesalazine—Infection—Timolol—hypertension	5.7e-06	6.46e-05	CcSEcCtD
Mesalazine—Headache—Verapamil—hypertension	5.69e-06	6.46e-05	CcSEcCtD
Mesalazine—Hypersensitivity—Telmisartan—hypertension	5.69e-06	6.46e-05	CcSEcCtD
Mesalazine—Cough—Lisinopril—hypertension	5.69e-06	6.45e-05	CcSEcCtD
Mesalazine—Nausea—Diltiazem—hypertension	5.68e-06	6.44e-05	CcSEcCtD
Mesalazine—Nausea—Indapamide—hypertension	5.68e-06	6.44e-05	CcSEcCtD
Mesalazine—Hyperhidrosis—Ramipril—hypertension	5.67e-06	6.43e-05	CcSEcCtD
Mesalazine—Asthenia—Trandolapril—hypertension	5.64e-06	6.4e-05	CcSEcCtD
Mesalazine—Shock—Timolol—hypertension	5.64e-06	6.4e-05	CcSEcCtD
Mesalazine—Feeling abnormal—Losartan—hypertension	5.64e-06	6.4e-05	CcSEcCtD
Mesalazine—Urticaria—Furosemide—hypertension	5.63e-06	6.39e-05	CcSEcCtD
Mesalazine—Nervous system disorder—Timolol—hypertension	5.63e-06	6.38e-05	CcSEcCtD
Mesalazine—Nausea—Carvedilol—hypertension	5.63e-06	6.38e-05	CcSEcCtD
Mesalazine—Asthenia—Enalapril—hypertension	5.62e-06	6.38e-05	CcSEcCtD
Mesalazine—Abdominal pain—Furosemide—hypertension	5.61e-06	6.36e-05	CcSEcCtD
Mesalazine—Body temperature increased—Furosemide—hypertension	5.61e-06	6.36e-05	CcSEcCtD
Mesalazine—Gastrointestinal pain—Losartan—hypertension	5.6e-06	6.35e-05	CcSEcCtD
Mesalazine—Dizziness—Valsartan—hypertension	5.6e-06	6.35e-05	CcSEcCtD
Mesalazine—Anorexia—Ramipril—hypertension	5.59e-06	6.34e-05	CcSEcCtD
Mesalazine—Urticaria—Betaxolol—hypertension	5.58e-06	6.33e-05	CcSEcCtD
Mesalazine—Skin disorder—Timolol—hypertension	5.57e-06	6.32e-05	CcSEcCtD
Mesalazine—Dizziness—Olmesartan—hypertension	5.57e-06	6.32e-05	CcSEcCtD
Mesalazine—Pruritus—Trandolapril—hypertension	5.57e-06	6.31e-05	CcSEcCtD
Mesalazine—Nausea—Doxazosin—hypertension	5.56e-06	6.31e-05	CcSEcCtD
Mesalazine—Myalgia—Lisinopril—hypertension	5.55e-06	6.3e-05	CcSEcCtD
Mesalazine—Chest pain—Lisinopril—hypertension	5.55e-06	6.3e-05	CcSEcCtD
Mesalazine—Arthralgia—Lisinopril—hypertension	5.55e-06	6.3e-05	CcSEcCtD
Mesalazine—Body temperature increased—Betaxolol—hypertension	5.55e-06	6.3e-05	CcSEcCtD
Mesalazine—Hyperhidrosis—Timolol—hypertension	5.55e-06	6.29e-05	CcSEcCtD
Mesalazine—Asthenia—Telmisartan—hypertension	5.54e-06	6.29e-05	CcSEcCtD
Mesalazine—Pruritus—Enalapril—hypertension	5.54e-06	6.29e-05	CcSEcCtD
Mesalazine—Anxiety—Lisinopril—hypertension	5.53e-06	6.28e-05	CcSEcCtD
Mesalazine—Diarrhoea—Clonidine—hypertension	5.52e-06	6.26e-05	CcSEcCtD
Mesalazine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—hypertension	5.51e-06	6.25e-05	CcSEcCtD
Mesalazine—Nausea—Fosinopril—hypertension	5.5e-06	6.23e-05	CcSEcCtD
Mesalazine—Discomfort—Lisinopril—hypertension	5.48e-06	6.22e-05	CcSEcCtD
Mesalazine—Hypotension—Ramipril—hypertension	5.48e-06	6.22e-05	CcSEcCtD
Mesalazine—Anorexia—Timolol—hypertension	5.47e-06	6.2e-05	CcSEcCtD
Mesalazine—Pruritus—Telmisartan—hypertension	5.47e-06	6.2e-05	CcSEcCtD
Mesalazine—Nausea—Eplerenone—hypertension	5.46e-06	6.2e-05	CcSEcCtD
Mesalazine—Urticaria—Losartan—hypertension	5.44e-06	6.17e-05	CcSEcCtD
Mesalazine—Dry mouth—Lisinopril—hypertension	5.43e-06	6.16e-05	CcSEcCtD
Mesalazine—Nausea—Nifedipine—hypertension	5.42e-06	6.15e-05	CcSEcCtD
Mesalazine—Abdominal pain—Losartan—hypertension	5.41e-06	6.14e-05	CcSEcCtD
Mesalazine—Body temperature increased—Losartan—hypertension	5.41e-06	6.14e-05	CcSEcCtD
Mesalazine—Nausea—Verapamil—hypertension	5.4e-06	6.12e-05	CcSEcCtD
Mesalazine—Asthenia—Captopril—hypertension	5.39e-06	6.12e-05	CcSEcCtD
Mesalazine—Diarrhoea—Trandolapril—hypertension	5.38e-06	6.11e-05	CcSEcCtD
Mesalazine—Vomiting—Valsartan—hypertension	5.38e-06	6.1e-05	CcSEcCtD
Mesalazine—Confusional state—Lisinopril—hypertension	5.37e-06	6.09e-05	CcSEcCtD
Mesalazine—Diarrhoea—Enalapril—hypertension	5.36e-06	6.08e-05	CcSEcCtD
Mesalazine—Hypotension—Timolol—hypertension	5.36e-06	6.08e-05	CcSEcCtD
Mesalazine—Hypersensitivity—Irbesartan—hypertension	5.36e-06	6.08e-05	CcSEcCtD
Mesalazine—Vomiting—Olmesartan—hypertension	5.35e-06	6.07e-05	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Ramipril—hypertension	5.35e-06	6.06e-05	CcSEcCtD
Mesalazine—Rash—Valsartan—hypertension	5.34e-06	6.05e-05	CcSEcCtD
Mesalazine—Dizziness—Clonidine—hypertension	5.33e-06	6.05e-05	CcSEcCtD
Mesalazine—Dermatitis—Valsartan—hypertension	5.33e-06	6.05e-05	CcSEcCtD
Mesalazine—Anaphylactic shock—Lisinopril—hypertension	5.32e-06	6.04e-05	CcSEcCtD
Mesalazine—Oedema—Lisinopril—hypertension	5.32e-06	6.04e-05	CcSEcCtD
Mesalazine—Pruritus—Captopril—hypertension	5.32e-06	6.03e-05	CcSEcCtD
Mesalazine—Hypersensitivity—Hydrochlorothiazide—hypertension	5.31e-06	6.03e-05	CcSEcCtD
Mesalazine—Rash—Olmesartan—hypertension	5.31e-06	6.02e-05	CcSEcCtD
Mesalazine—Insomnia—Ramipril—hypertension	5.31e-06	6.02e-05	CcSEcCtD
Mesalazine—Dermatitis—Olmesartan—hypertension	5.3e-06	6.02e-05	CcSEcCtD
Mesalazine—Headache—Valsartan—hypertension	5.3e-06	6.01e-05	CcSEcCtD
Mesalazine—Diarrhoea—Telmisartan—hypertension	5.29e-06	6e-05	CcSEcCtD
Mesalazine—Infection—Lisinopril—hypertension	5.29e-06	6e-05	CcSEcCtD
Mesalazine—Headache—Olmesartan—hypertension	5.28e-06	5.98e-05	CcSEcCtD
Mesalazine—Paraesthesia—Ramipril—hypertension	5.27e-06	5.98e-05	CcSEcCtD
Mesalazine—Shock—Lisinopril—hypertension	5.24e-06	5.94e-05	CcSEcCtD
Mesalazine—Asthenia—Perindopril—hypertension	5.23e-06	5.94e-05	CcSEcCtD
Mesalazine—Dyspnoea—Ramipril—hypertension	5.23e-06	5.93e-05	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Timolol—hypertension	5.23e-06	5.93e-05	CcSEcCtD
Mesalazine—Hypersensitivity—Furosemide—hypertension	5.23e-06	5.93e-05	CcSEcCtD
Mesalazine—Asthenia—Irbesartan—hypertension	5.22e-06	5.92e-05	CcSEcCtD
Mesalazine—Somnolence—Ramipril—hypertension	5.22e-06	5.92e-05	CcSEcCtD
Mesalazine—Thrombocytopenia—Lisinopril—hypertension	5.21e-06	5.91e-05	CcSEcCtD
Mesalazine—Dizziness—Trandolapril—hypertension	5.2e-06	5.9e-05	CcSEcCtD
Mesalazine—Tachycardia—Lisinopril—hypertension	5.19e-06	5.89e-05	CcSEcCtD
Mesalazine—Insomnia—Timolol—hypertension	5.19e-06	5.89e-05	CcSEcCtD
Mesalazine—Dizziness—Enalapril—hypertension	5.18e-06	5.88e-05	CcSEcCtD
Mesalazine—Asthenia—Hydrochlorothiazide—hypertension	5.17e-06	5.87e-05	CcSEcCtD
Mesalazine—Hypersensitivity—Betaxolol—hypertension	5.17e-06	5.87e-05	CcSEcCtD
Mesalazine—Skin disorder—Lisinopril—hypertension	5.17e-06	5.86e-05	CcSEcCtD
Mesalazine—Dyspepsia—Ramipril—hypertension	5.17e-06	5.86e-05	CcSEcCtD
Mesalazine—Pruritus—Perindopril—hypertension	5.16e-06	5.86e-05	CcSEcCtD
Mesalazine—Paraesthesia—Timolol—hypertension	5.15e-06	5.84e-05	CcSEcCtD
Mesalazine—Pruritus—Irbesartan—hypertension	5.14e-06	5.84e-05	CcSEcCtD
Mesalazine—Hyperhidrosis—Lisinopril—hypertension	5.14e-06	5.84e-05	CcSEcCtD
Mesalazine—Diarrhoea—Captopril—hypertension	5.14e-06	5.83e-05	CcSEcCtD
Mesalazine—Vomiting—Clonidine—hypertension	5.13e-06	5.82e-05	CcSEcCtD
Mesalazine—Dyspnoea—Timolol—hypertension	5.11e-06	5.8e-05	CcSEcCtD
Mesalazine—Dizziness—Telmisartan—hypertension	5.11e-06	5.8e-05	CcSEcCtD
Mesalazine—Pruritus—Hydrochlorothiazide—hypertension	5.1e-06	5.79e-05	CcSEcCtD
Mesalazine—Decreased appetite—Ramipril—hypertension	5.1e-06	5.79e-05	CcSEcCtD
Mesalazine—Somnolence—Timolol—hypertension	5.1e-06	5.78e-05	CcSEcCtD
Mesalazine—Asthenia—Furosemide—hypertension	5.09e-06	5.77e-05	CcSEcCtD
Mesalazine—Rash—Clonidine—hypertension	5.09e-06	5.77e-05	CcSEcCtD
Mesalazine—Dermatitis—Clonidine—hypertension	5.08e-06	5.76e-05	CcSEcCtD
Mesalazine—Anorexia—Lisinopril—hypertension	5.07e-06	5.75e-05	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Ramipril—hypertension	5.07e-06	5.75e-05	CcSEcCtD
Mesalazine—Fatigue—Ramipril—hypertension	5.06e-06	5.74e-05	CcSEcCtD
Mesalazine—Headache—Clonidine—hypertension	5.05e-06	5.73e-05	CcSEcCtD
Mesalazine—Dyspepsia—Timolol—hypertension	5.05e-06	5.73e-05	CcSEcCtD
Mesalazine—Hypersensitivity—Losartan—hypertension	5.04e-06	5.72e-05	CcSEcCtD
Mesalazine—Asthenia—Betaxolol—hypertension	5.04e-06	5.71e-05	CcSEcCtD
Mesalazine—Nausea—Valsartan—hypertension	5.03e-06	5.7e-05	CcSEcCtD
Mesalazine—Pruritus—Furosemide—hypertension	5.02e-06	5.69e-05	CcSEcCtD
Mesalazine—Constipation—Ramipril—hypertension	5.02e-06	5.69e-05	CcSEcCtD
Mesalazine—Nausea—Olmesartan—hypertension	5e-06	5.67e-05	CcSEcCtD
Mesalazine—Vomiting—Trandolapril—hypertension	5e-06	5.67e-05	CcSEcCtD
Mesalazine—Diarrhoea—Perindopril—hypertension	4.99e-06	5.66e-05	CcSEcCtD
Mesalazine—Decreased appetite—Timolol—hypertension	4.99e-06	5.66e-05	CcSEcCtD
Mesalazine—Vomiting—Enalapril—hypertension	4.98e-06	5.65e-05	CcSEcCtD
Mesalazine—Diarrhoea—Irbesartan—hypertension	4.98e-06	5.64e-05	CcSEcCtD
Mesalazine—Hypotension—Lisinopril—hypertension	4.97e-06	5.64e-05	CcSEcCtD
Mesalazine—Dizziness—Captopril—hypertension	4.97e-06	5.64e-05	CcSEcCtD
Mesalazine—Pruritus—Betaxolol—hypertension	4.97e-06	5.64e-05	CcSEcCtD
Mesalazine—Rash—Trandolapril—hypertension	4.96e-06	5.63e-05	CcSEcCtD
Mesalazine—Dermatitis—Trandolapril—hypertension	4.96e-06	5.62e-05	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Timolol—hypertension	4.95e-06	5.62e-05	CcSEcCtD
Mesalazine—Fatigue—Timolol—hypertension	4.95e-06	5.61e-05	CcSEcCtD
Mesalazine—Rash—Enalapril—hypertension	4.94e-06	5.6e-05	CcSEcCtD
Mesalazine—Dermatitis—Enalapril—hypertension	4.94e-06	5.6e-05	CcSEcCtD
Mesalazine—Diarrhoea—Hydrochlorothiazide—hypertension	4.93e-06	5.6e-05	CcSEcCtD
Mesalazine—Headache—Trandolapril—hypertension	4.93e-06	5.59e-05	CcSEcCtD
Mesalazine—Vomiting—Telmisartan—hypertension	4.91e-06	5.57e-05	CcSEcCtD
Mesalazine—Asthenia—Losartan—hypertension	4.91e-06	5.57e-05	CcSEcCtD
Mesalazine—Headache—Enalapril—hypertension	4.91e-06	5.57e-05	CcSEcCtD
Mesalazine—Pain—Timolol—hypertension	4.91e-06	5.56e-05	CcSEcCtD
Mesalazine—Rash—Telmisartan—hypertension	4.87e-06	5.53e-05	CcSEcCtD
Mesalazine—Dermatitis—Telmisartan—hypertension	4.87e-06	5.52e-05	CcSEcCtD
Mesalazine—Diarrhoea—Furosemide—hypertension	4.85e-06	5.5e-05	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Lisinopril—hypertension	4.85e-06	5.5e-05	CcSEcCtD
Mesalazine—Pruritus—Losartan—hypertension	4.84e-06	5.49e-05	CcSEcCtD
Mesalazine—Headache—Telmisartan—hypertension	4.84e-06	5.49e-05	CcSEcCtD
Mesalazine—Feeling abnormal—Ramipril—hypertension	4.84e-06	5.48e-05	CcSEcCtD
Mesalazine—Dizziness—Perindopril—hypertension	4.82e-06	5.47e-05	CcSEcCtD
Mesalazine—Insomnia—Lisinopril—hypertension	4.81e-06	5.46e-05	CcSEcCtD
Mesalazine—Dizziness—Irbesartan—hypertension	4.81e-06	5.45e-05	CcSEcCtD
Mesalazine—Diarrhoea—Betaxolol—hypertension	4.8e-06	5.45e-05	CcSEcCtD
Mesalazine—Gastrointestinal pain—Ramipril—hypertension	4.8e-06	5.44e-05	CcSEcCtD
Mesalazine—Nausea—Clonidine—hypertension	4.79e-06	5.43e-05	CcSEcCtD
Mesalazine—Paraesthesia—Lisinopril—hypertension	4.78e-06	5.42e-05	CcSEcCtD
Mesalazine—Vomiting—Captopril—hypertension	4.78e-06	5.42e-05	CcSEcCtD
Mesalazine—Dizziness—Hydrochlorothiazide—hypertension	4.77e-06	5.41e-05	CcSEcCtD
Mesalazine—Dyspnoea—Lisinopril—hypertension	4.74e-06	5.38e-05	CcSEcCtD
Mesalazine—Rash—Captopril—hypertension	4.74e-06	5.37e-05	CcSEcCtD
Mesalazine—Dermatitis—Captopril—hypertension	4.73e-06	5.37e-05	CcSEcCtD
Mesalazine—Somnolence—Lisinopril—hypertension	4.73e-06	5.37e-05	CcSEcCtD
Mesalazine—Feeling abnormal—Timolol—hypertension	4.73e-06	5.36e-05	CcSEcCtD
Mesalazine—Headache—Captopril—hypertension	4.71e-06	5.34e-05	CcSEcCtD
Mesalazine—Gastrointestinal pain—Timolol—hypertension	4.69e-06	5.32e-05	CcSEcCtD
Mesalazine—Dizziness—Furosemide—hypertension	4.69e-06	5.32e-05	CcSEcCtD
Mesalazine—Dyspepsia—Lisinopril—hypertension	4.68e-06	5.31e-05	CcSEcCtD
Mesalazine—Diarrhoea—Losartan—hypertension	4.68e-06	5.31e-05	CcSEcCtD
Mesalazine—Nausea—Trandolapril—hypertension	4.67e-06	5.3e-05	CcSEcCtD
Mesalazine—Urticaria—Ramipril—hypertension	4.66e-06	5.29e-05	CcSEcCtD
Mesalazine—Nausea—Enalapril—hypertension	4.65e-06	5.28e-05	CcSEcCtD
Mesalazine—Dizziness—Betaxolol—hypertension	4.64e-06	5.27e-05	CcSEcCtD
Mesalazine—Vomiting—Perindopril—hypertension	4.64e-06	5.26e-05	CcSEcCtD
Mesalazine—Abdominal pain—Ramipril—hypertension	4.64e-06	5.26e-05	CcSEcCtD
Mesalazine—Body temperature increased—Ramipril—hypertension	4.64e-06	5.26e-05	CcSEcCtD
Mesalazine—Decreased appetite—Lisinopril—hypertension	4.63e-06	5.25e-05	CcSEcCtD
Mesalazine—Vomiting—Irbesartan—hypertension	4.62e-06	5.24e-05	CcSEcCtD
Mesalazine—Rash—Perindopril—hypertension	4.6e-06	5.22e-05	CcSEcCtD
Mesalazine—Dermatitis—Perindopril—hypertension	4.6e-06	5.21e-05	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Lisinopril—hypertension	4.59e-06	5.21e-05	CcSEcCtD
Mesalazine—Nausea—Telmisartan—hypertension	4.59e-06	5.21e-05	CcSEcCtD
Mesalazine—Fatigue—Lisinopril—hypertension	4.59e-06	5.2e-05	CcSEcCtD
Mesalazine—Vomiting—Hydrochlorothiazide—hypertension	4.59e-06	5.2e-05	CcSEcCtD
Mesalazine—Rash—Irbesartan—hypertension	4.58e-06	5.2e-05	CcSEcCtD
Mesalazine—Dermatitis—Irbesartan—hypertension	4.58e-06	5.2e-05	CcSEcCtD
Mesalazine—Headache—Perindopril—hypertension	4.57e-06	5.18e-05	CcSEcCtD
Mesalazine—Urticaria—Timolol—hypertension	4.56e-06	5.17e-05	CcSEcCtD
Mesalazine—Headache—Irbesartan—hypertension	4.56e-06	5.17e-05	CcSEcCtD
Mesalazine—Constipation—Lisinopril—hypertension	4.55e-06	5.16e-05	CcSEcCtD
Mesalazine—Pain—Lisinopril—hypertension	4.55e-06	5.16e-05	CcSEcCtD
Mesalazine—Rash—Hydrochlorothiazide—hypertension	4.55e-06	5.16e-05	CcSEcCtD
Mesalazine—Dermatitis—Hydrochlorothiazide—hypertension	4.54e-06	5.15e-05	CcSEcCtD
Mesalazine—Abdominal pain—Timolol—hypertension	4.53e-06	5.14e-05	CcSEcCtD
Mesalazine—Body temperature increased—Timolol—hypertension	4.53e-06	5.14e-05	CcSEcCtD
Mesalazine—Dizziness—Losartan—hypertension	4.53e-06	5.13e-05	CcSEcCtD
Mesalazine—Headache—Hydrochlorothiazide—hypertension	4.52e-06	5.12e-05	CcSEcCtD
Mesalazine—Vomiting—Furosemide—hypertension	4.51e-06	5.12e-05	CcSEcCtD
Mesalazine—Rash—Furosemide—hypertension	4.47e-06	5.07e-05	CcSEcCtD
Mesalazine—Dermatitis—Furosemide—hypertension	4.47e-06	5.07e-05	CcSEcCtD
Mesalazine—Vomiting—Betaxolol—hypertension	4.46e-06	5.06e-05	CcSEcCtD
Mesalazine—Nausea—Captopril—hypertension	4.46e-06	5.06e-05	CcSEcCtD
Mesalazine—Headache—Furosemide—hypertension	4.44e-06	5.04e-05	CcSEcCtD
Mesalazine—Rash—Betaxolol—hypertension	4.43e-06	5.02e-05	CcSEcCtD
Mesalazine—Dermatitis—Betaxolol—hypertension	4.42e-06	5.02e-05	CcSEcCtD
Mesalazine—Headache—Betaxolol—hypertension	4.4e-06	4.99e-05	CcSEcCtD
Mesalazine—Feeling abnormal—Lisinopril—hypertension	4.39e-06	4.97e-05	CcSEcCtD
Mesalazine—Gastrointestinal pain—Lisinopril—hypertension	4.35e-06	4.94e-05	CcSEcCtD
Mesalazine—Vomiting—Losartan—hypertension	4.35e-06	4.94e-05	CcSEcCtD
Mesalazine—Nausea—Perindopril—hypertension	4.33e-06	4.92e-05	CcSEcCtD
Mesalazine—Hypersensitivity—Ramipril—hypertension	4.32e-06	4.9e-05	CcSEcCtD
Mesalazine—Nausea—Irbesartan—hypertension	4.32e-06	4.9e-05	CcSEcCtD
Mesalazine—Rash—Losartan—hypertension	4.31e-06	4.89e-05	CcSEcCtD
Mesalazine—Dermatitis—Losartan—hypertension	4.31e-06	4.89e-05	CcSEcCtD
Mesalazine—Headache—Losartan—hypertension	4.29e-06	4.86e-05	CcSEcCtD
Mesalazine—Nausea—Hydrochlorothiazide—hypertension	4.28e-06	4.86e-05	CcSEcCtD
Mesalazine—Urticaria—Lisinopril—hypertension	4.23e-06	4.8e-05	CcSEcCtD
Mesalazine—Hypersensitivity—Timolol—hypertension	4.23e-06	4.79e-05	CcSEcCtD
Mesalazine—Nausea—Furosemide—hypertension	4.21e-06	4.78e-05	CcSEcCtD
Mesalazine—Asthenia—Ramipril—hypertension	4.21e-06	4.78e-05	CcSEcCtD
Mesalazine—Abdominal pain—Lisinopril—hypertension	4.21e-06	4.77e-05	CcSEcCtD
Mesalazine—Body temperature increased—Lisinopril—hypertension	4.21e-06	4.77e-05	CcSEcCtD
Mesalazine—Nausea—Betaxolol—hypertension	4.17e-06	4.73e-05	CcSEcCtD
Mesalazine—Pruritus—Ramipril—hypertension	4.15e-06	4.71e-05	CcSEcCtD
Mesalazine—Asthenia—Timolol—hypertension	4.12e-06	4.67e-05	CcSEcCtD
Mesalazine—Nausea—Losartan—hypertension	4.06e-06	4.61e-05	CcSEcCtD
Mesalazine—Pruritus—Timolol—hypertension	4.06e-06	4.6e-05	CcSEcCtD
Mesalazine—Diarrhoea—Ramipril—hypertension	4.01e-06	4.55e-05	CcSEcCtD
Mesalazine—Diarrhoea—Timolol—hypertension	3.93e-06	4.45e-05	CcSEcCtD
Mesalazine—Hypersensitivity—Lisinopril—hypertension	3.92e-06	4.45e-05	CcSEcCtD
Mesalazine—Dizziness—Ramipril—hypertension	3.88e-06	4.4e-05	CcSEcCtD
Mesalazine—Asthenia—Lisinopril—hypertension	3.82e-06	4.33e-05	CcSEcCtD
Mesalazine—Dizziness—Timolol—hypertension	3.79e-06	4.3e-05	CcSEcCtD
Mesalazine—Pruritus—Lisinopril—hypertension	3.77e-06	4.27e-05	CcSEcCtD
Mesalazine—Vomiting—Ramipril—hypertension	3.73e-06	4.23e-05	CcSEcCtD
Mesalazine—Rash—Ramipril—hypertension	3.7e-06	4.2e-05	CcSEcCtD
Mesalazine—Dermatitis—Ramipril—hypertension	3.7e-06	4.19e-05	CcSEcCtD
Mesalazine—Headache—Ramipril—hypertension	3.68e-06	4.17e-05	CcSEcCtD
Mesalazine—Vomiting—Timolol—hypertension	3.65e-06	4.14e-05	CcSEcCtD
Mesalazine—Diarrhoea—Lisinopril—hypertension	3.64e-06	4.13e-05	CcSEcCtD
Mesalazine—Rash—Timolol—hypertension	3.62e-06	4.1e-05	CcSEcCtD
Mesalazine—Dermatitis—Timolol—hypertension	3.61e-06	4.1e-05	CcSEcCtD
Mesalazine—Headache—Timolol—hypertension	3.59e-06	4.08e-05	CcSEcCtD
Mesalazine—Dizziness—Lisinopril—hypertension	3.52e-06	3.99e-05	CcSEcCtD
Mesalazine—Nausea—Ramipril—hypertension	3.49e-06	3.95e-05	CcSEcCtD
Mesalazine—Nausea—Timolol—hypertension	3.41e-06	3.87e-05	CcSEcCtD
Mesalazine—Vomiting—Lisinopril—hypertension	3.38e-06	3.84e-05	CcSEcCtD
Mesalazine—Rash—Lisinopril—hypertension	3.36e-06	3.81e-05	CcSEcCtD
Mesalazine—Dermatitis—Lisinopril—hypertension	3.35e-06	3.8e-05	CcSEcCtD
Mesalazine—Headache—Lisinopril—hypertension	3.33e-06	3.78e-05	CcSEcCtD
Mesalazine—Nausea—Lisinopril—hypertension	3.16e-06	3.59e-05	CcSEcCtD
Mesalazine—CHUK—Disease—FGF2—hypertension	1.19e-06	2.27e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—GSTM1—hypertension	1.19e-06	2.27e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—LPL—hypertension	1.19e-06	2.26e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—RHOA—hypertension	1.19e-06	2.26e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—SLC2A4—hypertension	1.19e-06	2.25e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GCG—hypertension	1.19e-06	2.25e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—HTR2A—hypertension	1.18e-06	2.25e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—C3—hypertension	1.18e-06	2.24e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—H2AFX—hypertension	1.18e-06	2.24e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—PDGFRB—hypertension	1.18e-06	2.24e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—RPS6KB1—hypertension	1.18e-06	2.24e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—NOS3—hypertension	1.18e-06	2.24e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—PIK3R1—hypertension	1.18e-06	2.24e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—MTOR—hypertension	1.18e-06	2.23e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—FGF2—hypertension	1.17e-06	2.23e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—LPL—hypertension	1.17e-06	2.22e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—ADCY5—hypertension	1.17e-06	2.21e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—APOB—hypertension	1.16e-06	2.21e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—PRKCG—hypertension	1.16e-06	2.2e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—PIK3R1—hypertension	1.16e-06	2.2e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—PDGFB—hypertension	1.15e-06	2.18e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—ITGB3—hypertension	1.15e-06	2.18e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—PRKCA—hypertension	1.15e-06	2.18e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GOT1—hypertension	1.15e-06	2.18e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—ADCY5—hypertension	1.15e-06	2.18e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—FGFR1—hypertension	1.15e-06	2.17e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—GPX1—hypertension	1.14e-06	2.17e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—YWHAZ—hypertension	1.14e-06	2.16e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—CYP1A1—hypertension	1.13e-06	2.15e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—PRKCA—hypertension	1.13e-06	2.15e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—NGF—hypertension	1.13e-06	2.14e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—SPP1—hypertension	1.13e-06	2.14e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—HIF1A—hypertension	1.13e-06	2.14e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—AGT—hypertension	1.12e-06	2.13e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—CYP19A1—hypertension	1.12e-06	2.12e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—STK11—hypertension	1.12e-06	2.12e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—BCL2—hypertension	1.11e-06	2.11e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—CD36—hypertension	1.11e-06	2.11e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—LPL—hypertension	1.11e-06	2.11e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CALM1—hypertension	1.11e-06	2.1e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—H2AFX—hypertension	1.1e-06	2.09e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—PDGFRB—hypertension	1.1e-06	2.09e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—APOE—hypertension	1.1e-06	2.09e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—LEP—hypertension	1.1e-06	2.09e-05	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—ALB—hypertension	1.1e-06	2.08e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—PRKCD—hypertension	1.1e-06	2.08e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CCR5—hypertension	1.1e-06	2.08e-05	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—IL6—hypertension	1.09e-06	2.07e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CAV1—hypertension	1.09e-06	2.07e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—RELA—hypertension	1.09e-06	2.07e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—APOA1—hypertension	1.09e-06	2.07e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—ADCY5—hypertension	1.09e-06	2.06e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—MTOR—hypertension	1.09e-06	2.06e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL1B—hypertension	1.09e-06	2.06e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—PRKCG—hypertension	1.08e-06	2.05e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—KDR—hypertension	1.08e-06	2.05e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—PTGS2—hypertension	1.08e-06	2.04e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—HTR2A—hypertension	1.07e-06	2.04e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—PRKCA—hypertension	1.07e-06	2.04e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—C3—hypertension	1.07e-06	2.04e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—MTOR—hypertension	1.07e-06	2.03e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—YWHAZ—hypertension	1.06e-06	2.02e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—MTHFR—hypertension	1.06e-06	2e-05	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—PIK3R1—hypertension	1.05e-06	1.99e-05	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—NOS3—hypertension	1.05e-06	1.99e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—PTEN—hypertension	1.05e-06	1.99e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—PDGFB—hypertension	1.04e-06	1.98e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—FGFR1—hypertension	1.04e-06	1.97e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—FN1—hypertension	1.04e-06	1.97e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—F2—hypertension	1.04e-06	1.97e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—PRKCB—hypertension	1.04e-06	1.97e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—COMT—hypertension	1.04e-06	1.97e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—PPARA—hypertension	1.04e-06	1.96e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CCR5—hypertension	1.02e-06	1.94e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—PRKCD—hypertension	1.02e-06	1.94e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—HIF1A—hypertension	1.02e-06	1.94e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—PPARGC1A—hypertension	1.02e-06	1.94e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GNB3—hypertension	1.02e-06	1.94e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CDKN1A—hypertension	1.02e-06	1.94e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—AGT—hypertension	1.02e-06	1.93e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—PTEN—hypertension	1.02e-06	1.93e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—HMOX1—hypertension	1.02e-06	1.93e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—NOTCH1—hypertension	1.02e-06	1.93e-05	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—AKT1—hypertension	1.01e-06	1.91e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—CAT—hypertension	1e-06	1.9e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—AGT—hypertension	1e-06	1.9e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CALM1—hypertension	1e-06	1.9e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—MTHFR—hypertension	1e-06	1.9e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—APOE—hypertension	9.99e-07	1.89e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—LEP—hypertension	9.99e-07	1.89e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—EP300—hypertension	9.99e-07	1.89e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—MAPK8—hypertension	9.96e-07	1.89e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GNAS—hypertension	9.96e-07	1.89e-05	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—IL6—hypertension	9.9e-07	1.88e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CAV1—hypertension	9.9e-07	1.88e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—APOA1—hypertension	9.87e-07	1.87e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—CALM1—hypertension	9.87e-07	1.87e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IL1B—hypertension	9.85e-07	1.87e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—APOE—hypertension	9.83e-07	1.86e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—KDR—hypertension	9.79e-07	1.86e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—APOB—hypertension	9.75e-07	1.85e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—PDGFB—hypertension	9.74e-07	1.85e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—CAV1—hypertension	9.74e-07	1.85e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—APOA1—hypertension	9.72e-07	1.84e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—EP300—hypertension	9.71e-07	1.84e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—FGFR1—hypertension	9.69e-07	1.84e-05	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—AKT1—hypertension	9.67e-07	1.83e-05	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—PTGS2—hypertension	9.62e-07	1.82e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—HIF1A—hypertension	9.55e-07	1.81e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GSTM1—hypertension	9.48e-07	1.8e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—POMC—hypertension	9.46e-07	1.79e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—SRC—hypertension	9.44e-07	1.79e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—CDKN1A—hypertension	9.42e-07	1.79e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—PRKCB—hypertension	9.42e-07	1.79e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—F2—hypertension	9.42e-07	1.79e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—FN1—hypertension	9.42e-07	1.79e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—INS—hypertension	9.41e-07	1.78e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—PTEN—hypertension	9.4e-07	1.78e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CALM1—hypertension	9.35e-07	1.77e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—APOE—hypertension	9.32e-07	1.77e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—LPL—hypertension	9.31e-07	1.77e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CCL2—hypertension	9.26e-07	1.76e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CDKN1A—hypertension	9.25e-07	1.76e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CAV1—hypertension	9.23e-07	1.75e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—PTEN—hypertension	9.23e-07	1.75e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—NOTCH1—hypertension	9.22e-07	1.75e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—APOA1—hypertension	9.21e-07	1.75e-05	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—AKT1—hypertension	9.14e-07	1.73e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—ADCY5—hypertension	9.11e-07	1.73e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—IGF1—hypertension	9.1e-07	1.73e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—AKT2—hypertension	9.1e-07	1.73e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GPX1—hypertension	9.08e-07	1.72e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—MAPK8—hypertension	9.03e-07	1.71e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—PRKCA—hypertension	8.99e-07	1.71e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—CYP1A1—hypertension	8.99e-07	1.71e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—EP300—hypertension	8.96e-07	1.7e-05	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—MYC—hypertension	8.96e-07	1.7e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—CD36—hypertension	8.85e-07	1.68e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—EP300—hypertension	8.8e-07	1.67e-05	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—AKT1—hypertension	8.77e-07	1.66e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—SRC—hypertension	8.72e-07	1.65e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—NOS2—hypertension	8.68e-07	1.65e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—SERPINE1—hypertension	8.64e-07	1.64e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—NOTCH1—hypertension	8.6e-07	1.63e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—POMC—hypertension	8.58e-07	1.63e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—PPARG—hypertension	8.56e-07	1.62e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—SRC—hypertension	8.56e-07	1.62e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—INS—hypertension	8.53e-07	1.62e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—POMC—hypertension	8.44e-07	1.6e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—INS—hypertension	8.4e-07	1.59e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CCL2—hypertension	8.4e-07	1.59e-05	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—PTEN—hypertension	8.39e-07	1.59e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—MTHFR—hypertension	8.38e-07	1.59e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—FGF2—hypertension	8.37e-07	1.59e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—RHOA—hypertension	8.34e-07	1.58e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—EGFR—hypertension	8.28e-07	1.57e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IGF1—hypertension	8.25e-07	1.57e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—PIK3R1—hypertension	8.25e-07	1.57e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—NOS3—hypertension	8.25e-07	1.57e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—AKT2—hypertension	8.25e-07	1.56e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—PPARA—hypertension	8.22e-07	1.56e-05	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—EP300—hypertension	8e-07	1.52e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—AGT—hypertension	7.96e-07	1.51e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—INS—hypertension	7.96e-07	1.51e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—SERPINE1—hypertension	7.84e-07	1.49e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—CALM1—hypertension	7.83e-07	1.49e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—MYC—hypertension	7.81e-07	1.48e-05	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—AKT1—hypertension	7.81e-07	1.48e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—APOE—hypertension	7.8e-07	1.48e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—TGFB1—hypertension	7.79e-07	1.48e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—RELA—hypertension	7.77e-07	1.47e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—CAV1—hypertension	7.73e-07	1.47e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—APOA1—hypertension	7.71e-07	1.46e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—ALB—hypertension	7.7e-07	1.46e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—AKT2—hypertension	7.69e-07	1.46e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—EGFR—hypertension	7.64e-07	1.45e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—MTOR—hypertension	7.62e-07	1.44e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—FGF2—hypertension	7.59e-07	1.44e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—RHOA—hypertension	7.56e-07	1.43e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—EGFR—hypertension	7.5e-07	1.42e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—NOS3—hypertension	7.48e-07	1.42e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—PIK3R1—hypertension	7.48e-07	1.42e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—PIK3R1—hypertension	7.36e-07	1.4e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—NOS3—hypertension	7.36e-07	1.4e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CXCL8—hypertension	7.32e-07	1.39e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—SERPINE1—hypertension	7.31e-07	1.39e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—FGF2—hypertension	7.08e-07	1.34e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—RHOA—hypertension	7.05e-07	1.34e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—RELA—hypertension	7.04e-07	1.34e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—NOS3—hypertension	6.98e-07	1.32e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—PIK3R1—hypertension	6.98e-07	1.32e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—MTOR—hypertension	6.91e-07	1.31e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—PPARG—hypertension	6.8e-07	1.29e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—PTGS2—hypertension	6.74e-07	1.28e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—POMC—hypertension	6.7e-07	1.27e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—INS—hypertension	6.67e-07	1.26e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CXCL8—hypertension	6.64e-07	1.26e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—MMP9—hypertension	6.62e-07	1.26e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CDKN1A—hypertension	6.6e-07	1.25e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—PTEN—hypertension	6.58e-07	1.25e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—MTOR—hypertension	6.44e-07	1.22e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—MAPK8—hypertension	6.44e-07	1.22e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL6—hypertension	6.36e-07	1.21e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—EP300—hypertension	6.28e-07	1.19e-05	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—AKT1—hypertension	6.22e-07	1.18e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—ALB—hypertension	6.11e-07	1.16e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—SRC—hypertension	6.1e-07	1.16e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—MMP9—hypertension	6e-07	1.14e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CDKN1A—hypertension	5.98e-07	1.13e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—PTEN—hypertension	5.97e-07	1.13e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—VEGFA—hypertension	5.95e-07	1.13e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—PTEN—hypertension	5.87e-07	1.11e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—IL6—hypertension	5.87e-07	1.11e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—AKT1—hypertension	5.87e-07	1.11e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—PIK3R1—hypertension	5.85e-07	1.11e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—NOS3—hypertension	5.85e-07	1.11e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—MAPK8—hypertension	5.84e-07	1.11e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IL6—hypertension	5.77e-07	1.09e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—EP300—hypertension	5.69e-07	1.08e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—EP300—hypertension	5.6e-07	1.06e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CDKN1A—hypertension	5.58e-07	1.06e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—PTEN—hypertension	5.57e-07	1.06e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—SRC—hypertension	5.54e-07	1.05e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—MYC—hypertension	5.47e-07	1.04e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—TGFB1—hypertension	5.46e-07	1.04e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—AKT1—hypertension	5.42e-07	1.03e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—VEGFA—hypertension	5.39e-07	1.02e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—EGFR—hypertension	5.35e-07	1.01e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—AKT1—hypertension	5.32e-07	1.01e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—EP300—hypertension	5.31e-07	1.01e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—SRC—hypertension	5.16e-07	9.79e-06	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—MYC—hypertension	4.96e-07	9.41e-06	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—TGFB1—hypertension	4.95e-07	9.39e-06	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—EGFR—hypertension	4.85e-07	9.2e-06	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—AKT1—hypertension	4.83e-07	9.17e-06	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—PTEN—hypertension	4.66e-07	8.84e-06	CbGpPWpGaD
Mesalazine—PTGS2—Disease—MYC—hypertension	4.63e-07	8.78e-06	CbGpPWpGaD
Mesalazine—PTGS2—Disease—TGFB1—hypertension	4.62e-07	8.76e-06	CbGpPWpGaD
Mesalazine—PTGS2—Disease—EGFR—hypertension	4.53e-07	8.58e-06	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—TP53—hypertension	4.49e-07	8.52e-06	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—EP300—hypertension	4.45e-07	8.43e-06	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—IL6—hypertension	4.11e-07	7.8e-06	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—TP53—hypertension	4.07e-07	7.73e-06	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—AKT1—hypertension	3.79e-07	7.2e-06	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IL6—hypertension	3.73e-07	7.07e-06	CbGpPWpGaD
Mesalazine—PTGS2—Disease—IL6—hypertension	3.48e-07	6.6e-06	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—AKT1—hypertension	3.44e-07	6.52e-06	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—AKT1—hypertension	3.39e-07	6.42e-06	CbGpPWpGaD
Mesalazine—PTGS2—Disease—AKT1—hypertension	3.21e-07	6.09e-06	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—AKT1—hypertension	2.69e-07	5.1e-06	CbGpPWpGaD
